doi.org/10.1016/s0140-6736(18)30475-6

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

,

,

The Lancet88.50

Volume: 391, Issue: 10127, Pages: 1263 - 1273

Published: Mar 1, 2018

Paper Fields

Paper Details

Title

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

DOI

doi.org/10.1016/s0140-6736(18)30475-6

Published Date

Mar 1, 2018

Journal

Volume

391

Issue

10127

Pages

1263 - 1273

Notes

History